GlassScriptPhysician profile
Rena R Hu
NPI 1275774374
$2,424.50
in general payments reported to CMS, 2019-2025
19 companies · $484 in 2025
The $484 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $95.28 · 2021: $303 · 2022: $423 · 2023: $289 · 2024: $376 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $440.48 | 2019-2025 | Gardasil 9, Gardasil, Vaxneuvance |
| Ethicon US, LLC | $260.10 | 2019-2025 | Harmonic, Enseal |
| Therapeuticsmd, INC. | $239.09 | 2019-2021 | |
| Pfizer INC. | $218.70 | 2023-2025 | |
| Agile Therapeutics, INC. | $183.79 | 2021-2024 | Twirla |
| Abbvie INC. | $169.71 | 2019-2024 | |
| Hologic Sales and Service, LLC | $129.65 | 2021-2025 | Myosure Tissue Removal Device, Aptima |
| Glaxosmithkline, LLC. | $122.98 | 2019 | |
| Organon LLC | $116.15 | 2021-2025 | Nexplanon |
| Medical Device Business Services, INC. | $111.00 | 2024 | Vistaseal |
| Amgen INC. | $95.86 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.47 | 2022 | |
| Roche Diagnostics Corporation | $61.80 | 2020-2021 | |
| Sage Therapeutics, LLC | $60.48 | 2021-2022 | |
| Coopersurgical, INC. | $49.10 | 2019-2023 | Paragard T 380a |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $34.36 | 2019-2022 | |
| Shield Therapeutics INC | $26.15 | 2023 | Accrufer |
| Exeltis, USA INC. | $21.34 | 2025 | Slynd |
| Axonics, INC. | $17.29 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rena Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.